Tower Research Capital (TRC)’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,524
| Closed | -$22.3K | – | 5524 |
|
|
2025
Q1 | $22.3K | Buy |
+26,524
| New | +$22.3K | ﹤0.01% | 2860 |
|
|
2023
Q4 | – | Sell |
-3,230
| Closed | -$1.19K | – | 6136 |
|
|
2023
Q3 | $1.19K | Buy |
+3,230
| New | +$1.19K | ﹤0.01% | 5385 |
|
|
2023
Q2 | – | Sell |
-7,600
| Closed | -$5K | – | 6289 |
|
|
2023
Q1 | $5K | Buy |
+7,600
| New | +$5K | ﹤0.01% | 4988 |
|
|
2022
Q4 | – | Sell |
-14,136
| Closed | -$12K | – | 6287 |
|
|
2022
Q3 | $12K | Sell |
14,136
-7,828
| -36% | -$6.65K | ﹤0.01% | 4365 |
|
|
2022
Q2 | $20K | Buy |
21,964
+5,548
| +34% | +$5.05K | ﹤0.01% | 3802 |
|
|
2022
Q1 | $10K | Buy |
+16,416
| New | +$10K | ﹤0.01% | 4335 |
|
|
2021
Q4 | – | Sell |
-124,260
| Closed | -$74K | – | 6501 |
|
|
2021
Q3 | $74K | Buy |
+124,260
| New | +$74K | ﹤0.01% | 2661 |
|